Drug-Coated Balloon Versus Drug-eluting Stent Angioplasty for Treatment of Chronic Total Occlusion - The DCB-CTO Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

Also called NCT07369765

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Biruni University (from the registry)
Registry
  • NCT NCT07369765
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Türkiye (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07369765. Randomized; no masking; primary purpose treatment. Start 2025-08-28 (actual); primary completion 2026-08-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Drug-Coated Balloon Versus Drug-eluting Stent Angioplasty for Treatment of Chronic Total Occlusion - The DCB-CTO Trial
Acronym
DCB-CTO
Intervention (Device)
Drug-Eluting Stent Group
Intervention (Device)
Drug Coated Balloon Group
Lead sponsor
Biruni University (class: other)

Record details

Record id
cardio:ct-nct07369765
Content hash
0da441d3fda3839c216b11a97c6dd8d9a234d63c2bb3c0ea058ed9dd1424cfff